Felipe Vilardell Villellas
Degree: PhD
fvilardell.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/B-8141-2015
Groups
Publications
-
Ortiz-Brugues, A; Marti-Laborda, RM; Azon-Masoliver, A; Vilardell-Vilellas, F; Casanova-Seuma, JM
Lymphoproliferative CD30-positive disorder in a patient with a folliculotropic mycosis fungoides
Journal Der Deutschen Dermatologischen Gesellschaft 15 577-579. .
-
Huerva, V; Traveset, AE; Vilardell, F
Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia
Ocular Immunology And Inflammation 25 284-286. .
-
Gasol Cudos, A.; Morales Murillo, S.; Panades Siurana, M. J.; Vilardell Villellas, F.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.; Salud Salvia, A.
Change in treatment decisions according to Oncotype Dx Recurrence Score in node positive and negative, estrogen-receptor positive (ER+), HER2 negative breast cancer in a single institution
BREAST 32 92-93. .
-
Moreno, R; Rojas, LA; Villellas, FV; Soriano, VC; Garcia-Castro, J; Fajardo, CA; Alemany, R
Human Menstrual Blood-Derived Mesenchymal Stem Cells as Potential Cell Carriers for Oncolytic Adenovirus
Stem Cells International 2017 3615729-3615729. .
-
Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X
Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies
Blood 127 1907-1911. .
-
García de la Fuente MR; Vilardell-Villellas F; Martí-Laborda RM; Casanova-Seuma JM
Primary cutaneous small-to-medium-sized CD4+ T-cell lymphoma with a granulomatous component
ACTAS DERMO-SIFILIOGRAFICAS 107 86-88. .
-
Gas-Ruiz C; Ros-López SE; Vilardell-Villella F; Mias-Carballal C; Villalobos-Mori R; De-la-Fuente-Juárez MC; Baena-Fustegueras JA; Olsina-Kissler JJ
Lethal pseudomembranous colitis in an immunocompetent patient.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 107 117-119. .
-
Papis, D.; Branchi, V.; Gomez, L.; Herrerias, F.; Vilardell, F.; Gonzalez, M.; Olsina, J.J.
Abdominal tuberculosis mimicking Crohn's disease's exacerbation: A clinical, diagnostic and surgical dilemma. A case report
International Journal of Surgery Case Reports 6 122-125. .
-
García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X
Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
CLINICAL & TRANSLATIONAL ONCOLOGY 16 243-256. .
-
Barcelo C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N
Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
CANCER RESEARCH 74 1190-1199. .
-
Gomez-Martin C; Plaza JC; Pazo-Cid R; Salud A; Pons F; Fonseca P; Leon A; Alsina M; Visa L; Rivera F; Galan MC; Del Valle E; Vilardell F; Iglesias M; Fernandez S; Landolfi S; Cuatrecasas M; Mayorga M; Jose Paulés M; Sanz-Moncasi P; Montagut C; Garralda E; Rojo F; Hidalgo M; Lopez-Rios F
Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab
Journal of Clinical Oncology 31 4445-4445. .
-
Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients
BREAST CANCER RESEARCH AND TREATMENT 139 87-93. .
Projects
- Análisis del microambiente tumoral del melanoma cutáneo asociado al perfil genético y/o a la aparición de resistencias
- Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
- Análisis del secretoma en el melanoma humano asociado al perfil genético y a la aparición de resistencias. Identificación de biomarcadores y/o dianas terapéuticas de aplicación clínica
- POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
- ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
- Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
- CONTRATOS POSTDOCTORALES DE PERFECCIONAMIENTO SARA BORRELL